Impact medicine through the development of machine learning based AI framework and tools that can bring to light extraordinary clinical insights that lie "hidden" within existing medical data
Medial EarlySign offers a unique, algorithm-powered toolset to provide practitioners with clinical decision-support tools and driving a new generation of population health solutions. Using a combination of EHR data, we are developing a suite of solutions for healthcare organizations that aid in the early detection of cancers, metabolic and chronic diseases, delivering better and more accurate treatments in everyday, medical care. Our goal is to make these insights accessible to all stakeholders including healthcare organizations, doctors, and eventually patients. We believe that our technology is setting a new standard in data-driven healthcare, one that will ultimately enhance the practice of modern medicine.
Integrating cutting edge machine learning science with clinical expertise
Validated on nearly 1 million patients, and ongoing clinical studies with over 20 million patients in 14 leading institutions around the world